Brendan Kelly, Ph.D.
InvestorSenior Director, Healthcare Venture Investments at Leaps by Bayer
Boston, Massachusetts, United States
Find your path to Brendan
880 people in our graph share verified history with Brendan — schools, employers, funds. One of them is your warm intro.
Deep NisharunlockedBrendan: together at Stanford University (2015–2017)
×7Brendan: together at Stanford University
×2Brendan: together at University of Barcelona
×2Brendan: together at Leaps by Bayer
About
Brendan Kelly combines medicinal chemistry and computational drug discovery work at Trinity College Dublin, University of Toronto and Stanford with founding A2a Pharmaceuticals and peer‑reviewed publications to assess biotech platforms.
Invests in
BiotechHealthtechMedical Devices
Experience
- Leaps by BayerSenior Director, Healthcare Venture Investmentscurrent2026 — presentCambridge, Massachusetts, United States
- Lightstone VenturesPrincipal2024 — 2026Boston, Massachusetts, United States
- Lightstone VenturesVice President2021 — 2024Boston, Massachusetts, United States
- A2A PharmaceuticalsCo-Founder and Strategic Advisor2016 — 2021
- A2A PharmaceuticalsHead Of Research And Development2017 — 2018
- Q32 Bio Inc.Director, New Product Planning2021Cambridge, Massachusetts, United States
- Q32 Bio Inc.Assoc. Director, New Product Planning2020 — 2021Cambridge, Massachusetts, United States
- OS FundLife Sciences Venture Advisor2017 — 2021Greater Boston
- L.E.K. ConsultingLife Sciences Consultant2020Boston, Massachusetts, United States
- L.E.K. ConsultingSenior Life Science Specialist2019 — 2020Greater Boston
- L.E.K. ConsultingLife Science Specialist2018 — 2019Boston
- Stanford UniversityPostdoctoral Researcher, Computational Drug Discovery2015 — 2017Palo Alto, California
- University Health Network, University of TorontoPostdoctoral Fellow2013 — 2015Toronto, Canada
- Trinity College Dublin, Department of BiochemistryResearcher2012 — 2013Dublin, Ireland
- University of BarcelonaVisiting Researcher2012Greater Barcelona Metropolitan Area
- Trinity College DublinLecturer2009 — 2012Dublin, Ireland
Skills & more
Drug Discovery8Molecular Modeling14Molecular Dynamics10Computational Chemistry8Organic Chemistry18Spectroscopy9University Teaching4Medicinal Chemistry18NMR Spectroscopy3Assay Development3Science5Research6
+7 more
ChemistryNMROrganic SynthesisScientific WritingMolecular BiologyLife SciencesLinuxLanguages English · French · Spanish
From Brendan's professional profile.
Colleagues at Leaps by Bayer
Frequently asked questions
- Who is Brendan Kelly, Ph.D.?
- Brendan Kelly combines medicinal chemistry and computational drug discovery work at Trinity College Dublin, University of Toronto and Stanford with founding A2a Pharmaceuticals and peer‑reviewed publications to assess biotech platforms.
- Where does Brendan Kelly, Ph.D. work?
- Brendan Kelly, Ph.D. is Senior Director, Healthcare Venture Investments at Leaps by Bayer.
- What does Brendan Kelly, Ph.D. invest in?
- Brendan Kelly, Ph.D. invests in Biotech, Healthtech, Medical Devices.
- Where did Brendan Kelly, Ph.D. go to school?
- Brendan Kelly, Ph.D. studied at Trinity College Dublin (Doctor of Philosophy (Ph.D.), Design, synthesis and evaluation of alpha 2 adrenoceptor antagonists for the treatment of depression); Trinity College Dublin (Bachelor of Science (BSc), Medicinal Chemistry).
Same school
Also attended Trinity College Dublin224
Eoghan McCabeCo-founder & CEO of Fin (formerly Intercom)Justin HallPartner at Golden Gate VenturesBriac BombrunInvestment Associate at Burda Principal InvestmentsBrian SmigaVenture Partner, Co-Founder at Alpha PartnersTom StaffordCo-founder at DST GlobalRichard HurleyManaging Director, Head of IR at Seed Healthcare
+ 218 more
Shared employers
Also worked at Lightstone Ventures19
Adam BrucePartner, Chief Financial and Chief Operating Officer at Flare Capital PartnersMike CarusiManaging Partner at Lightstone VenturesCaroline GaynorPartner at Lightstone VenturesHanson S. Gifford, IIIPartner at Lightstone VenturesMark DeemOperating Partner at Lightstone VenturesOlivia PeterVice President, Finance at Lightstone Ventures
+ 13 more
Also worked at A2A Pharmaceuticals2
Also worked at OS Fund3
Also worked at L.E.K. Consulting192
Chris BischoffInvestment Team at General CatalystMattias LjungmanInvestor at Moonfire VenturesJessica SchultzPartner at NorthzoneFrancois PrinslooInvestor at MedicxiMiranda GuerreroExecutive Assistant at Sapphire VenturesStacey HeroInvestor at Third Rock Ventures
+ 186 more